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ABSTRACT
Backgroud: Present study was designed to assess the possibility of in-
vivo neuropharmacological effects of the ethanolic extract of Syzygium 
aromaticum flowering buds by using behavioral models of mice.
Methods: Anxiolytic effects of the extract were assessed using open 
field test (OFT), hole cross test (HCT), elevated plus maze (EPM), and 
hole board test (HBT) respectively; while antidepressant properties 
were determined using forced swimming test (FST), and tail suspension 
test (TST). Finally thiopental sodium (TS)-induced sleeping time test 
helped us to evaluate the sedative-hypnotic potential of the extract. 
Results: In OFT and HCT, the movement of the mice decreased 
significantly (*p<0.005) for the extract treated groups when compare 
to control. This decrease indicates the suppression of locomotor 
activities of mice (from 1st-5th observation periods). Moreover, the 
increase of the spending time in EPM open arm, and head dipping in 
HBT endorsed the anxiolytic-like behavior of the extract. In FST and 
TST, S. aromaticum extract significantly (*p<0.05, **p<0.001) reduced 
the immobility time of the mice. Approx. 29% and 34% reduction of 
the immobility time were found in FST for 250 mg/kg, and 500 mg/
kg b.w. doses respectively, which clearly indicates the presence 
of the antidepressant compounds in extract. Finally, TS-induced 
sleeping time test confirmed the potency of the sedative response 
of the extract (sleeping duration were 45.4±2.6 minutes for control, 
whereas 87.0±1.79 minutes for 500 mg/kg b.w. extract treated 
group). The observed neurological response may be due to binding 
of any phytoconstituent with gamma-amino-butyric acid (GABA
A
) or 
benzodiazepine (BZD) receptors. 
Conclusion: Our study results suggest that the ethanolic extract 
of S. aromaticum possess remarkable sedative, antidepressant and 
anxiolytic activities with a demand of further investigation for the drug 
development program.
Keywords: Syzygium aromaticum (SA), Open field test (OFT), Hole cross test (HCT), Elevated plus maze (EPM), Forced swimming test (FST), 
Thiopental sodium (TS)
INTRODUCTION
Neurological disorders are disorders of nervous 
system where brain, spine, and nerves are involved. 
Most common mental illness are- depression, anxi-
ety, schizophrenia, autism, obsessive-compulsive 
disorder etc.1 At least 20% of adult populations 
suffer in anxiety and depressionin whole world.2-4 
Heavy sweating, nervousness, dizziness, anhedo-
nia, depressed mood, fatigue, suicidal tendencies, 
low self-esteem, psychomotor and gastrointestinal 
disturbances etc. are the symptoms of anxiety and 
depression.5 Higher cognitive centers, hippocam-
pus, thalamus and hypothalamus of the brain and 
some important neurotransmitters are involved 
in anxiety. This is due to decrease of the inhibi-
tory γ-amino-butyric-acid (GABA) or increase of 
the excitatory neurotransmission through gluta-
mate.6 On the other hand, during depression the 
central monoaminergic function may impair.7 
Benzodiazepines, a popular group of drug used 
worldwide for the patients suffer in depression and 
anxiety.8,9 However, long-term use of benzodiaze-
pines may incur unfavorable and undesirable risks 
and side effects.10 As a result, it is an urgent need 
to search an alternative to get more efficacious, less 
toxic and better tolerated therapeutic agents.
S. aromaticum, a spice known as clove (family- 
Myrtaceae) native to Maluka islands, Indonesia.11 
This plant parts contain glycosides, hydroxyphenyl 
propens, hydrophenyl benzoic acid, hydrolizable 
tannins, elagic, ferulic, salicylic acids, flavonoids, 
kaempferol, essential oil, α-humulen, β-pinene, 
farnesol, benzaldehyde, 2-heptanone, ethyl hexa-
noatelimonene etc. phytoconstituents.12-14 This plant 
is used for the stomach upset, chill, toothache, head-
ache, cold, arthritis, rheumatism, bruises, burn, bron-
chitis, ulcer, asthma, minor infection, colic, nausea 
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etc.15 The main phytoconstituent of S. aromatic is 
eugenol, which is reported for possessing many 
pharmacological properties- analgesic, anti-oxidant, 
anti-inflammatory, anti-allergic, anti-cartinogenic, 
anti-mutasenic etc activities. Although having 
several uses of S. aromaticum, very little information 
is known yet about the neurological efficacy of this 
plant part. That’s why our present study is designing 
to assess the neuropharmacological potency of the 
ethanolic extract of S. aromaticum flowering buds. 
METHODS
Drugs and reagents
Thiopental sodium USP, and diazepam were 
purchased from Sigma-Aldrich corporation (USA), 
whereas ethanol form Merck (Germany). All other 
reagents used in this study were analytical grades. 
Collection of plant parts
Dried flowering buds of S. aromaticum were collected 
from Riaz-Uddin Bazar, Chittagong, Bangladesh. 
After collection, dried bulbs were sorted from dirt, 
washed thoroughly by water, and then dried on 
sunlight. Identification of this plant part was done 
from Bangladesh National Herbarium, Dhaka, 
Bangladesh (Accession no- 42764).
Preparation of plant extract
After sun drying for 15 days, the flowering buds 
were ground into course powder through grinding 
machine. Powdered materials were submerged into 
2000 ml (~99.5%) ethanol in an air-tight container 
for 2 weeks with occasional stirring. The macerated 
product was allowed to filter by cloth, and then 
using by Whatman filter paper. After evaporating 
at room temperature (~25°C), we had obtained a 
brawny sticky residue (crude ethanolic extract of 
S. aromaticum flowering buds). 
Experimental animals
Both sexes (25-30g) of Swiss albino mice were 
collected from the animal house of Jahangirnagar 
University. Mice were given rodent food and water 
ad-libitum (7 days before starting the experiment to 
finishing the experiment). Mice were kept in metal 
cages [condition: (20±5)°C, RH: (55-70)%].
Animal grouping 
For all experiments, mice were selected randomly 
and subdivided into 4 groups (each group consist 
of 5 mice): groups for control, standard treated, and 
two different concentrations of the S. aromaticum 
extract treated. After finishing each session of the 
experiments, mice were get off from the test appa-
ratus, and apparatus was wiped thoroughly by using 
10% ethanol. 
Acute Toxicity Test
For observing acute toxicity effect, the animal were 
subdivided into control, and test groups respectively. 
S. aromaticum extract was administered orally at 
1000, 2000, and 3000 mg/kg b.w. of mice doses respec-
tively. Allergic symptoms, mortality of the mice were 
observed closely for next 72 hours period.16
Behavioral studies of anxiolytic activities
Open field test (OFT)
We have followed the method of Amin et  al. for 
conducting OFT.17 The OFT board is made by 
white poly-wood (72x72x36 cm3). The ground of 
the apparatus is divided and marked into 16 equal 
squares; and the full apparatus is surrounded by 
glass wall. Mice of different groups- control (vehi-
cle treated), standard (diazepam 1 mg/kg treated), 
and crude (250 mg and 500 mg/kg b.w. of mice) 
treated were set down in center of OFT board; and 
the movement of mice were recorded for 3 minutes 
period at 0, 30, 60, 90, and 120 minutes after admin-
istering respective doses. 
Hole cross test (HCT)
HCT was done according to the procedure of 
Sharmin et  al., 2018.18 Mice were divided into 
control (vehicle treated), standard treated (diaz-
epam: 1 mg/kg b.w.), and crude extract treated 
groups (250 mg/kg, and 500 mg/kg b.w. of mice). 
For this test, a wooden cage (30×20×14 cm3) was 
used, where there were partitions with holes. Mice 
were stand on one side of test chamber after dosing; 
and observations of their movements were done 
for 3 minutes periods at 0, 30, 90, and 120 minutes 
interval time. This test was adopted for screening 
anxiolytic activities of the crude extract.
Elevated plus maze test (EPM)
EPM test is useful for assessing anxiolytic-like 
activity of plant extract. Apparatus of EPM test was 
made by wood with 2 closed arms and 2 open arms 
crossed each other. It was placed at 40 cm above 
the ground and forming a plus-sign figure. Mouse 
was placed in middle area of the EPM device, and 
closely observed to its free movement. Mice were 
grouped randomly and given their respective doses. 
The spending time in each arm, and the entries 
in closed and opened arm were counted at 0, 30, 
60, 90, 120 minutes (for 5  minutes spells) after 
administering respective doses. Details procedure 
was described in our previous paper, Rashid et al., 
2018.19 
Hole board test (HBT)
In HBT, a wooden box (40x40x25 cm3) was placed 
35 cm above the ground level. The apparatus 
contained 16 equidistant holes (diameter- 3  cm). 
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Mice of control group had received vehicle (1% 
tween 80 in water), standard group received diaz-
epam (1 mg/kg b.w.) and two test groups had 
received extract (250 mg/kg and 500 mg/kg b.w.). 
Mouse was placed in center area of the box, and 
then allowed to move freely in board for 5 minutes. 
The number of head dipping during this period was 
recorded for individual mouse.18
Antidepressant activity test
Forced swimming test (FST)
FST is one of the popular methods for screening 
antidepressant-like compounds using rodent 
behavioral model. For this test, we followed the 
procedures of Amin et al., 2018 with slight modi-
fication.17 This test uses cylindrical tank which 
was made of glass with a dimension of (30×20×15 
cm3). The mice of control group were given vehicle 
orally, whereas diazepam (1 mg/kg b.w.) was given 
to the standard treated group intraperitonially. 
Mice of test groups received the crude ethanolic 
extract of S. aromaticum (250 mg/kg, and 500 mg/
kg b.w. of mice). Immobile time of each mouse was 
recorded by using a stopwatch after dosing. We 
have recorded the immobile time for 6 minutes 
period; however last 240 seconds data were taken 
for analysis. 
Tail suspension test (TST)
TST is the rapid and reliable technique for find-
ing antidepression activity of the plant extract. A 
TST box (Dimension: 55x60x11.5 cm3) made of 
plastic was used for this test. Mouse was hung by 
its tail, and then suspended for 6 minutes period 
for observation. 20 mice of 4 groups were taken to 
be treated with standard (1 mg/kg b.w. diazepam), 
vehicle (control), and the plant extract (250 mg/
kg and 500 mg/kg b.w.). The method described by 
Steru et  al., 1985 was followed here.20 Immobile 
time of each mouse after hanging was counted and 
recorded. 
Sedative-hypnotic activity test
Thiopental Sodium (TS)-induced sleeping  
time test
TS-induced sleeping time test was done as stated 
in the method of Moniruzzaman et al., 2015.16 TS 
(40 mg/kg b.w. of mice) was injected intraperito-
nially to animal after 30 minutes of the treatment of 
extract, standard, and vehicle (control) respectively. 
A stopwatch was used to record the duration for 
losing righting reflex, and sleep induced by TS.
Statistical analysis
Data were presented as (mean± SEM). One-way 
ANOVA followed by Dennett’s t-test were done 
using SPSS 19.0 software. Data were compared 
with control group (*p<0.05, and **p<0.001 were 
significant and highly significant values). Origin 
Pro (Ver.-8.5, Origin Lab. Corp., USA), and 
Microsoft office excel (2010) are used for prepar-
ing graphs. 
RESULTS
In this study, the neuropharmacological activities 
of crude ethanolic extract of S. aromaticum flower-
ing bud were assessed. We found that crude extract 
at 1000, 2000, and 3000 mg/kg doses didn’t produce 
any adverse or allergic symptoms during 72 hours 
observation period. As a result it can be said that the 
studied crude extract may be safe upto 3000 mg/kg 
b.w. of mice. Based on this cytotoxic data, we have 
selected the doses (250 and 500 mg/kg b.w. doses) 
which were much lower than toxic concentration 
(>3000 mg/kg b.w. of mice).16
Evaluation of the behavioral studies
Open Field Test
In OFT, S. aromaticum extract at both doses (250, 
and 500 mg/kg b.w.) significantly (*p<0.05, and 
**p<0.001) reduce the movement of mice with dose 
dependant manner (Figure 1). For 500 mg/kg b.w. 
of mice dose, the total number of squares traveled 
reduced significantly upto 120 minutes. 
Hole Cross Test
The experimental result of HCT is shown in 
(Figure  2). Mice treated with S. aromaticum 
extract (250, and 500 mg/kg b.w.) decrease 
locomotion activities significantly (*p<0.05, 
**p<0.001). The subsequence of this reduction of 
the movement was found from 2nd (30 minutes) to 
5th observation (120 minutes) after treatment. We 
found the dose dependant response of S. aromat-
icum, which is comparable to the decrease of the 
movement by standard drug (diazepam: 1 mg/kg 
b.w.)
Elevated plus maze test 
EPM test of S. aromaticum ethanolic extract is used 
to observe the anxiolytic-like effect as reported 
previously. Treatment of mice by the plant extract 
(500 mg/kg) showed that the time duration spent 
in open arm of EPM increased significantly 
(*p<0.05, **p<0.001); whereas in closed arm the 
time decreases slightly (Figure. 3). Plant extract at 
the conc. (250 mg/kg) also shows similar activity, 
although the activity is not significant. We found 
dose dependant response of the extract. The higher 
duration of residing in open arm mean the lower 
level of anxiety of mice. 
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Hole Board Test
In HBT, the ethanolic extract of S. aromaticum 
at 500 mg/kg b.w dose significantly increased 
the number of head dipping. Approx. (46.20 ± 
3.79), (75.00 ± 4.55) head dips were found for 
250, and 500 mg/kg b.w. extract respectively. The 
result is comparable to the standard drug diaze-
pam (59.40 ± 7.61). The overall result is shown in 
Table 1. 
Evaluation of the antidepressant activity 
test
Forced Swimming Test
Administration of both doses of S. aromaticum 
ethanolic extract significantly (*p<0.05, **p<0.001) 
decreases the immobility time in FST. The effect 
follows dose dependant trend which is plotted in 
(Figure 4).
Tail Suspension Test
The result of TST test is shown in Figure 5 It was 
found that ethanolic extract of S. aromaticum 
Figure 3  Effect of S. aromaticum extract in 
elevated plus maze test of mice. Open 
triangle (▽), and open circle (◯) 
represent the time spent in close arm 
and open arm of the EPM apparatus 
respectively. SA 250 = S. aromaticum 
250 mg/kg b.w., and SA 500 = 
S. aromaticum 500 mg/kg b.w. of mice.
Figure 4  Effect of S. aromaticum ethanolic 
extract on forced swimming test of 
mice. Open triangle (△) represents the 
immobility time of the mice. SA 250 = 
S. aromaticum 250 mg/kg b.w., and SA 
500 = S. aromaticum 500 mg/kg b.w. of 
mice.
Figure 1  Effect of the ethanolic extract of S. aro-
maticum flowering bud in open field 
test of mice.
Figure 2  Effect of the ethanolic extract of S. aro-
maticum flowering bud in hole cross 
test of mice.
Figure 5  Effect of S. aromaticum ethanolic extract 
on tail suspension test in mice. Open 
triangle (△) represents the immobil-
ity time of the mice. SA 250 = S. aro-
maticum 250 mg/kg b.w., and SA 500 = 
S. aromaticum 500 mg/kg b.w. of mice.
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decreases immobility time of the mice proportion-
ally with increase of extract concentration. For 250, 
and 500 mg/kg b.w. of the extract, immobilization 
times were (128 ± 2.98) and (123.6 ± 3.56) seconds 
respectively. On the other hand, immobilize time 
was (176.4 ± 10.12) seconds for diazepam. The 
result is significant (*p<0.05, **p<0.001), and 
follows dose dependant response.
Sedative-hypnotic activity test
Thiopental Sodium (TS)-induced sleeping 
time test
It was found that S. aromaticum (250, and 500 mg/
kg b.w.) significantly shorten the onset of sleep-
ing time, and also increase the duration of sleep. 
The overall result has been shown in Table 2. We 
found that the effects of S.  aromaticum extract 
follow dose dependant manner. Maximum sleep-
ing   duration  (87 ± 1.79) minutes was found for 
500 mg/kg b.w. of extract. In contrast, this value is 
(51.4 ± 6.4) minutes diazepam (1 mg/kg b.w.).
DISCUSSION
Plants are considered as alternative sources of the 
therapeutic agents from the early age of human civi-
lization. In modern era, over 50% of the drugs come 
from natural origins (plant and animal sources). 
These natural products are playing important 
roles in drug development program.21 On the 
other hand, proper diagnosis and treatment of the 
patients suffer in anxiety and depression is much 
challenging, moreover not so satisfactory level still 
now.22 Although many new drugs developed in last 
two decades, none of them is perfect choice as the 
side effect is not in acceptable limit. That’s why we 
try to find out more efficient, safer and cost effective 
neurological agents from plant origin. In this study, 
we try to assess the neuropharmacological efficacy 
of S. aromaticum ethanolic extract using swiss 
albino mice model.
OFT and HCT are the two reliable neuropharma-
cological models used to assess the anxiolytic-like 
efficacy of the compounds. In OFT study, we found 
that the extract treated groups at both doses (250, 
500 mg/kg b.w.) significantly (*p<0.05, **p<0.001) 
decreased the number of movement of mice when 
compared to the vehicle treated group (control). 
Highest decrease was found after 120 minutes of the 
extract administration. We found dose dependant 
response of the extract, and the efficacy is compa-
rable to the effect of standard drug (diazepam).
Anxiolytic agents can decrease the fearful attitude 
of the mice in OFT and HCT apparatuses which can 
decrease the locomotor activity of mice.23,24 In both 
tests, motor activities of the mice decreases grad-
ually from 1st to 5th observation periods (as move-
ment of mice decreases), which confirm the time 
dependency of the anxiolytic effect. The anxiolyt-
ic-like potency of S. aromaticum was also assessed 
by EPM and HBT tests. EPM is one of the reliable 
and highly sensitive test methods for identifying 
selective anxiogenic and anxiolytic effect of the 
agents. The preference of spending maximum time 
in open arm of the EPM apparatus is the reflection 
of anxiolytic-like effect.18 We found that 500 mg/
kg b.w. of S. aromaticum extract (given to the mice 
orally) can increased the spending time in opened 
arms significantly rather than closed arms. In HBT, 
the increased number of head dipping reflects an 
indication of the anxiolytic-like activity.25 In our 
study, we found that 500 mg/kg of S. aromati-
cum ethanolic extract significantly increased the 
number of head dipping (almost 3 times than 
control group), which endorsed the anxiolytic-like 
efficiency of the extract.26 Phytochemical screen-
ing claimed that S. aromaticum possesses high 
amount of essential oil- eugenol (major constitu-
ent), eugenyl acetate, β-caryophyllene etc.27 Nassar 
et  al., 2007 isolated some other phytoconstituents 
from the ethanolic fraction of S. aromaticum, like- 
flavonoids (tamarixetin 3-O-b-D-glucopyranoside, 
ombuin 3-O-b-D-glucopyranoside, quercetin), 
aldehyde (ferulic aldehyde), limonin, phenol, 
hydrolizable tannins, elagic,salicylic acids etc.28 
Presence of these phytoconstituents may be respon-
sible for the CNS effects.29 The possible reason of 
the anxiolytic effect is due to hyperpolarization of 
CNS by the interaction with gamma-amino-butyric 
Table 2  Effect of S. aromaticum ethanolic extract on thiopental 










Control 0.1 ml/mouse (oral) 34.6 ± 0.93 45.40 ± 2.60 0
Diazepam 1 mg/kg (i.p.) 18.4 ± 0.93** 51.40 ± 6.40 13.21
S. aromaticum 250 mg/kg b.w. of 
mice (oral)
19.8 ± 0.80** 74.00 ± 2.92** 62.99
S. aromaticum 500 mg/kgb.w. of 
mice (oral)
13.0 ± 0.77** 87.00 ± 1.79** 91.63
Values are presented as mean± SEM (n=5). One way ANOVA followed by Dunnet’s t-test were 
done. *p<0.05, **p<0.001 as compared to control.
Table 1 Effect of S. aromaticum extract in hole board test of mice.
Group Dose Number of head dipping
Control 0.1 ml/mouse (oral) 27.80 ±4.97
Diazepam 1 mg/kg b.w. of mice (i.p.) 59.40 ± 7.61*
S. aromaticum 250 mg/kg b.w. of mice (oral) 46.20 ± 3.79
S. aromaticum 500 mg/kg b.w. of mice (oral) 75.00 ± 4.55**
Values are presented as mean ± SEM (n=5). One way ANOVA followed by Dunnet’s t-test
were done. *p<0.05, **p<0.001 as compared to control.
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acid (GABAA) or benzodiazepine (BZD) receptor. 
GABA is a well-known inhibitory neurotransmitter 
in CNS, and the anxiolytic activities of most of the 
drugs show by actingon GABAA receptor. Therefore 
our proposed hypothesis stands that the anxiolyt-
ic-like effect of S. aromaticum extract may be due 
to interacting/binding of any phytoconstituent with 
GABAA receptor.
29,30 
Anxiety and anxiety disorders are found in acute 
phase of depression. Antidepressant drugs help to 
sleep better, and also used for treating social anxiety 
disorder, generalized anxiety disorder etc. That’s why 
strong antidepressant drugs with anxiolytic activity 
are very important. For screening the antidepressant 
activity of the agents, TST and FST are valid, fast and 
reliable methods.31 Duration of immobility in TST 
and FST is considered as screening parameter of this 
activity. Both doses of S. aromaticum extract signifi-
cantly decreased the period of immobility of mice 
(approx. 29% and 34% reduction of immobility time 
than control were found for 250, and 500 mg/kg b.w. 
doses). The effect follows dose dependant manner 
and also comparable with standard drug diazepam. 
S. aromaticum plant extract contains many constit-
uents including flavonoids, tannin, glycosides etc. 
Flavonoid and tannin possesses antioxidant activ-
ities. Thus they can prevent oxidative stress which 
is believed one of the reasons of depression. Again 
they also can wield receptors and enzyme activi-
ties.32 In intestine, flavonoid and glycoside can be 
hydrolyzed to form aglycon; and after absorption 
they convert into conjugated metabolites. These 
metabolites transport to the brain tissues and exert 
antidepressant activity.33
Thiopental Sodium (TS)-induced sleeping time 
test was performed for assessing sedative-hypnotic 
potential of S. aromaticum ethanolic extract. TS is 
a hypnosis-inducing agent, and it induces hypnosis 
by increasing GABA mediated inhibition in post 
synaptic membrane via allosteric modification 
of GABAA receptors. S. aromaticum extract give 
significant dose dependent (*p<0.05, **p<0.001) 
sedation. The onset of sleeping for 500 mg/kg b.w. 
dose gives much quicker response than diazepam 
(1  mg/kg b.w). The sedative effect of this extract 
may be due to the hyperpolarization by interact-
ing with GABAA receptor which may increase the 
GABA concentration in brain.18 So it is assumed 
that the effect of S. aromaticum extract may be 
similar as benzodiazepines.
CONCLUSION
Based on the results found in this study, we have 
concluded that crude ethanolic extract of S. aromat-
icum possesses significant antidepressant, sedative, 
and anxiolytic-like efficacies. The potency of the 
extract to increase the sleeping duration in sleeping 
time test, decreasing the immobility time in FST 
and TST, decrease of locomotor activities in OFT 
and HCT, increase of the head dipping in HBT- 
all the tests endorsed the significant neurological 
activities of S. aromaticum extract. Therefore, there 
is a good possibility to have bioactive ingredients in 
this extract for the treatment of insomnia, depres-
sion and anxiety. However for confirming the 
neurological activity and potential therapeutic use, 
further research is suggested specially the isolation 
of the responsible bioactive compounds and their 
clinical trial are recommended. 
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